Skip to main content
Innoviva, Inc. logo

Innoviva, Inc. — Investor Relations & Filings

Ticker · INVA ISIN · US45781M1018 LEI · 549300ACOX4QTBES6535 US Financial and insurance activities
Filings indexed 1,226 across all filing types
Latest filing 2019-03-06 Director's Dealing
Country US United States of America
Listing US INVA

About Innoviva, Inc.

https://www.inva.com/

Innoviva, Inc. is a diversified holding company that manages a portfolio of royalty-generating assets and operates a commercial-stage biopharmaceutical platform. The company's core royalty business is centered on respiratory therapies, providing a stable cash flow. Through its subsidiary, Innoviva Specialty Therapeutics, it focuses on developing and commercializing innovative treatments for patients in critical care and with infectious diseases. Innoviva's strategy involves leveraging its financial assets to invest in healthcare opportunities with high unmet medical needs, aiming to advance differentiated therapies and build a diverse portfolio of healthcare assets.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2019-03-06 English
FORM 4
Director's Dealing
2019-03-06 English
FORM 8K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated February 28, 2019. It announces the dismissal of the previous independent auditor Ernst & Young LLP and the engagement of a new auditor Grant Thornton LLP. It includes details about the auditor change, absence of disagreements or reportable events, and a letter from the former auditor. This is a typical auditor change announcement filed on Form 8-K, which is a regulatory filing. It is not a full audit report, annual report, or financial statement filing. The document length is about 5,438 characters, which is consistent with a Form 8-K announcement. Therefore, the appropriate classification is Regulatory Filings (RNS).
2019-02-28 English
FORM 4
Director's Dealing
2019-02-28 English
FORM 4
Director's Dealing
2019-02-28 English
SC 13D
Major Shareholding Notification
2019-02-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.